# Evaluating Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study

> **NCT07698951** · NA · RECRUITING · sponsor: **Recross Cardio, Inc.** · enrollment: 15 (estimated)

## Conditions studied

- PFO
- PFO - Patent Foramen Ovale
- Cryptogenic Stroke
- Patent Foramen Ovale
- PFO-associated Stroke

## Interventions

- **DEVICE:** Recross P3 Occluder (P3O) System

## Key facts

- **NCT ID:** NCT07698951
- **Lead sponsor:** Recross Cardio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-17
- **Primary completion:** 2027-07
- **Final completion:** 2029-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07698951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07698951, "Evaluating Percutaneous Repair Of The Atrial Septum With A Novel PFO Occluder: The PROTEA-PFO OUS Study". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07698951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*